Abstract
Study objectives Sleep disorders are medical disorders of the sleep architecture of a subject, and based on their severity they can interfere with mental, emotional and physical functioning. The most common ones are insomnia, narcolepsy, sleep apnea, bruxism, etc. There is an increment risk of developing sleep disorders in elderly like insomnia, periodic leg movements, rapid eye movement (REM) behaviour disorders,sleep disorder breathing, etc. Consequently, their accurate diagnosis and classification are important steps towards an early stage treatment that could save the life of a patient. The Electroencephalographic (EEG) signal is the most sensitive and important biosignal, which is able to capture the brain sleep activity that is sensitive to sleep. In this study, we attempt to analyse EEG sleep activity via complementary cross-frequency coupling (CFC) estimates that will further feed a classifier, aiming to discriminate sleep disorders.
Methods We adapted an open EEG Database with recordings that were grouped into seven sleep disorders and a healthy control. The EEG brain activity from common sensors has been analysed with two basic types of cross-frequency coupling (CFC). Finally, a Random Forest (RF) classification model was built on CFC patterns, that were extracted from non-cyclic alternating pattern (CAP) epochs.
Results Our RFCFC model succeeded a 74% multiclass accuracy. Both types of CFC, PAC and AAC patterns contribute to the accuracy of the RF model, thus supporting their complementary information.
Conclusion CFC patterns, in conjunction with the RF classifier proved a valuable biomarker for the classification of sleep disorders.
Statement of Significance In this study, we developed an efficient model that is able to perform sleep disorder diagnosis by analysing the EEG sleep activity under the framework of cross-frequency coupling (CFC) with the support of RF. CFC has been proven an important mechanism that supports the integration of neural activity of different frequency content through a nested hierarchy of their oscillatory pattern inherent to distinct neural functions. Our results suggest that CFC can reflect aberrant physiological interactions during sleep stages, which are sensitive to differentiate sleep disorders. Therefore, our RFCFC model can be a valuable mental health tool for an accurate classification of those somnipathies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study involves the analysis of preexisting datasets that have been downloaded from: https://physionet.org/content/capslpdb/1.0.0/
Clinical Protocols
https://physionet.org/content/capslpdb/1.0.0/
Funding Statement
Funding SID was supported by MRC grant MR/K004360/1 (Behavioral and Neurophysiological Effects of Schizophrenia Risk Genes: A Multi-locus, Pathway Based Approach) and by a MARIE-CURIE COFUND EU-UK Research Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Everything is described in the original articles. https://physionet.org/content/capslpdb/1.0.0/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.